Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

BioStar Ventures

Investor type Venture Capital
Founders Louis Cannon


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 41
Average round size
The average size of a deal this fund participated in
Portfolio companies 26
Rounds per year 2.16
Lead investments 4
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 8
Key employees 5
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Medical Device
  • Health Care
  • Medical
  • Biotechnology
  • Manufacturing

BioStar Ventures appeared to be the VC, which was created in 2003. The company was established in North America in United States. The main department of described VC is located in the Petoskey.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the BioStar Ventures, startups are often financed by Safeguard Scientifics, Pontifax, Menlo Ventures. The meaningful sponsors for the fund in investment in the same round are Triventures, Safeguard Scientifics, MedFocus Fund. In the next rounds fund is usually obtained by Safeguard Scientifics, HealthQuest Capital, HBM Healthcare Investments AG.

The current fund was established by Louis Cannon. We also calculated 5 valuable employees in our database.

Opposing the other organizations, this BioStar Ventures works on 7 percentage points less the average amount of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in 2-6 deals every year. When the investment is from BioStar Ventures the average startup value is 10-50 millions dollars. Speaking about the real fund results, this VC is 2 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2014. Despite it in 2019 the fund had an activity. The increased amount of exits for fund were in 2014.

Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Robotics, Medical Device. Among the various public portfolio startups of the fund, we may underline Corindus, SynergEyes, Domain Surgical The fund has exact preference in a number of founders of portfolio startups.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of BioStar Ventures:
Typical Co-investors
BioStar Ventures is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after BioStar Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


Health Care
Medical Device
$75M20 Jul 2022 Italy, Tuscany, Italy

Ablative Solutions

Health Care
Medical Device
$91M13 Jun 2022 San Jose, California, United States


Developer Platform
Medical Device
$20M22 Jun 2020 Salt Lake City, Utah, United States

Aria CV

Health Care
Medical Device
$31M25 Feb 2020 Saint Paul, Minnesota, United States


Medical Device
$19M26 Feb 2019 Massachusetts, United States

Trice Medical

Health Care
Health Diagnostics
Medical Device
$18M14 Jan 2019 Pennsylvania, United States

Ablative Solutions

Health Care
Medical Device
$77M03 Jan 2019 San Jose, California, United States


Health Care
Medical Device
$70M27 Apr 2018 Israel, North District, Israel


Medical Device
$25M16 Mar 2018 Massachusetts, United States


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent BioStar Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: